Governed by the Board of Directors with the Scientific Advisory Committee, Audit Committee and Executive Board Committee providing key scientific and management guidance for decision making, the DNDi Executive Team implements the R&D strategy, manages the global portfolio, allocates resources, fundraises, and advocates.
Board Of Directors
The Board of Directors is made up of 10 to 13 members including a patient advocate, with each of six Founding Partners nominating one board member. In principle, Board members serve for a term of four years. The Board of Directors elects the Chair, the Secretary and the Treasurer among its members.
Scientific Advisory Commitee
The Scientific Advisory Committee (SAC) is composed of not less than 5 prominent scientists with expertise in various scientific disciplines relating to drug discovery and development, and/or to the specific reality of neglected diseases and patients. The committee operates independently of the Board of Directors.
DNDi has a global team of around 200 committed staff and close consultants. Our team is based at DNDi‘s Switzerland headquarters and regional offices in Brazil, United States of America, Democratic Republic of the Congo, Kenya, India, Malaysia, and Japan.